Naltrexone for Impulse Control Disorders in Parkinson's Disease

NCT01052831 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Impulse Control Disorder
Parkinson Disease

Interventions

DRUG: Naltrexone
DRUG: Placebo

Sponsor

University of Pennsylvania

Collaborators

[object Object]